Renovaro Secures U.S. Patent for AI Drug Discovery Platform
June 3, 2025
Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets Renovaro Inc., a clinical-stage precision medicine company, announced that its subsidiary BioSymetrics has
